420500login-checkStudy Supports Expanded Use of HCV-Infected Liver Donation |
– Post-transplant survival similar between recipients with active or prior HCV infection
With the advent of direct-acting antiviral therapy for hepatitis C virus (HCV) in the post-liver transplant setting, we are seeing more and more HCV-infected donor livers offered to patients awaiting liver transplant. Post-liver transplant outcomes for patients with HCV-associated hepatocellular carcinoma (HCC) who receive HCV-infected donor livers are not well established.
A recent study, published in Clinical Gastroenterology and Hepatology, utilized the United Network for Organ Sharing (UNOS) registry to classify patients with HCV-related HCC (with either prior infection or active viremia) who received HCV-infected donor livers. Overall, the post-liver transplant survival outcomes were similar between recipients with active HCV infection and those with prior infection. Clinically, this study supports consideration of expanded use of HCV-infected liver donation to improve access to liver transplantation. Read more on MedPage Today.
420500login-checkStudy Supports Expanded Use of HCV-Infected Liver Donation |